Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Esophageal carcinoma‏‎ (1 revision)
  2. LEOPARD syndrome‏‎ (1 revision)
  3. Incidentaloma‏‎ (1 revision)
  4. Quiz:L4E uropathology (2018)‏‎ (1 revision)
  5. Acute pneumonia‏‎ (1 revision)
  6. Case 118‏‎ (1 revision)
  7. Sinus invasion‏‎ (1 revision)
  8. Oligohydramnios‏‎ (1 revision)
  9. Papillary carcinoma of the breast‏‎ (1 revision)
  10. Polar Spongioblastoma‏‎ (1 revision)
  11. Slide assessment checklist‏‎ (1 revision)
  12. PEA‏‎ (1 revision)
  13. Bowel obstruction‏‎ (1 revision)
  14. Medullomyoblastoma‏‎ (1 revision)
  15. Prolapse‏‎ (1 revision)
  16. Gastric snakeskin appearance‏‎ (1 revision)
  17. An introduction to endocrine pathology‏‎ (1 revision)
  18. Renal epithelial and stromal tumour‏‎ (1 revision)
  19. Primary lymphoid organs‏‎ (1 revision)
  20. Rheumatology‏‎ (1 revision)
  21. Cytokeratin 34 beta E12‏‎ (1 revision)
  22. Ampulla‏‎ (1 revision)
  23. Bortezomib‏‎ (1 revision)
  24. Avascular necrosis‏‎ (1 revision)
  25. Quiz:L4E dermatopathology (2018)‏‎ (1 revision)
  26. Gastrointestinal bleeding‏‎ (1 revision)
  27. Hidradenoma‏‎ (1 revision)
  28. Ganglion‏‎ (1 revision)
  29. OP:Motto‏‎ (1 revision)
  30. Plasmacytosis mucosae‏‎ (1 revision)
  31. Case 80‏‎ (1 revision)
  32. Pyrosequencing‏‎ (1 revision)
  33. CAP Molecular Diagnosis of Lung Cancer‏‎ (1 revision)
  34. Gilbert syndrome‏‎ (1 revision)
  35. ERG‏‎ (1 revision)
  36. Corneal button‏‎ (1 revision)
  37. Adenomyosis‏‎ (1 revision)
  38. Knee replacement specimen grossing‏‎ (1 revision)
  39. Acromegaly‏‎ (1 revision)
  40. Quiz:L4E rule 4 (2018)‏‎ (1 revision)
  41. Molecular Genetic Diagnosis‏‎ (1 revision)
  42. Sinonasal teratocarcinosarcoma‏‎ (1 revision)
  43. Atrophic carcinoma‏‎ (1 revision)
  44. Urology links‏‎ (1 revision)
  45. Steatoma‏‎ (1 revision)
  46. Micropapillary breast carcinoma‏‎ (1 revision)
  47. CAP Breast Cancer and Molecular‏‎ (1 revision)
  48. Fibroma‏‎ (1 revision)
  49. GA‏‎ (1 revision)
  50. HMB-45‏‎ (1 revision)
  51. Luteinized follicular cyst‏‎ (1 revision)
  52. Larynx‏‎ (1 revision)
  53. Lung carcinoma‏‎ (1 revision)
  54. Duodenitis‏‎ (1 revision)
  55. Eosinophilic granuloma‏‎ (1 revision)
  56. Ion AmpliSeq Cancer Hotspot Panel v2‏‎ (1 revision)
  57. H3F3A‏‎ (1 revision)
  58. LM‏‎ (1 revision)
  59. Ankylosing spondylitis‏‎ (1 revision)
  60. CD3‏‎ (1 revision)
  61. Environmental causes of death‏‎ (1 revision)
  62. GFAP‏‎ (1 revision)
  63. Grossing notes‏‎ (1 revision)
  64. Treatment‏‎ (1 revision)
  65. Iron deficiency anemia‏‎ (1 revision)
  66. Enterogenous cyst‏‎ (1 revision)
  67. Glands‏‎ (1 revision)
  68. Formalin-fixed paraffin-embedded‏‎ (1 revision)
  69. Cytotoxic T-lymphocyte-associate antigen 4‏‎ (1 revision)
  70. Dragon NaturallySpeaking‏‎ (1 revision)
  71. Sequestrum‏‎ (1 revision)
  72. Mixed papilloma‏‎ (1 revision)
  73. Prevalence‏‎ (1 revision)
  74. Syndrome‏‎ (1 revision)
  75. CAP Molecular Diagnosis of AML‏‎ (1 revision)
  76. Tattoo‏‎ (1 revision)
  77. Positron emission tomography‏‎ (1 revision)
  78. Xanthogranuloma‏‎ (1 revision)
  79. Adrenoleukodystrophy‏‎ (1 revision)
  80. Site‏‎ (1 revision)
  81. CCC‏‎ (1 revision)
  82. Hyperthyroidism‏‎ (1 revision)
  83. Extranodal extension‏‎ (1 revision)
  84. Prostatitis‏‎ (1 revision)
  85. Ewing-like tumours‏‎ (1 revision)
  86. Mole‏‎ (1 revision)
  87. Chromosomal polymorphisms‏‎ (1 revision)
  88. Prognosis‏‎ (1 revision)
  89. GBM‏‎ (1 revision)
  90. Pituicytoma‏‎ (1 revision)
  91. CD23‏‎ (1 revision)
  92. Case 100‏‎ (1 revision)
  93. Maxilla‏‎ (1 revision)
  94. Left colon‏‎ (1 revision)
  95. Case:Notes/IHC‏‎ (1 revision)
  96. Smooth muscle tumours‏‎ (1 revision)
  97. Post-graduate year‏‎ (1 revision)
  98. Secretory carcinoma‏‎ (1 revision)
  99. Adrenal gland cysts‏‎ (1 revision)
  100. Angiogenesis‏‎ (1 revision)
  101. Case 119‏‎ (1 revision)
  102. Case 39‏‎ (1 revision)
  103. Molecular neuropathology‏‎ (1 revision)
  104. Serous cystadenoma‏‎ (1 revision)
  105. Dermolipectomy‏‎ (1 revision)
  106. Fellow‏‎ (1 revision)
  107. Transportation related Deaths‏‎ (1 revision)
  108. Nodular glomerulosclerosis‏‎ (1 revision)
  109. IPFitis‏‎ (1 revision)
  110. Tissue microarray‏‎ (1 revision)
  111. Anaplastic carcinoma‏‎ (1 revision)
  112. LSC‏‎ (1 revision)
  113. Pneumatosis cystoides intestinalis‏‎ (2 revisions)
  114. PubMed Identifier‏‎ (2 revisions)
  115. Everolimus‏‎ (2 revisions)
  116. Cystectomy‏‎ (2 revisions)
  117. Transitional cell carcinoma‏‎ (2 revisions)
  118. Polyps‏‎ (2 revisions)
  119. Nodular hyperplasia‏‎ (2 revisions)
  120. Case 109‏‎ (2 revisions)
  121. Case 104‏‎ (2 revisions)
  122. RP‏‎ (2 revisions)
  123. LCA‏‎ (2 revisions)
  124. Laboratory information system‏‎ (2 revisions)
  125. Indeterminate margin‏‎ (2 revisions)
  126. Endocarditis‏‎ (2 revisions)
  127. Intimal sarcoma‏‎ (2 revisions)
  128. Esophageal cancer‏‎ (2 revisions)
  129. Bazex syndrome‏‎ (2 revisions)
  130. Central neurocytoma‏‎ (2 revisions)
  131. Rezum‏‎ (2 revisions)
  132. List of Microdeletion Syndromes‏‎ (2 revisions)
  133. Pemphigoid‏‎ (2 revisions)
  134. Thrombomodulin‏‎ (2 revisions)
  135. Case 83‏‎ (2 revisions)
  136. CD5‏‎ (2 revisions)
  137. Pseudoseizures‏‎ (2 revisions)
  138. Autosomal recessive polycystic kidney disease‏‎ (2 revisions)
  139. Colonic leiomyoma‏‎ (2 revisions)
  140. Poorly differentiated thyroid carcinoma‏‎ (2 revisions)
  141. Case 43‏‎ (2 revisions)
  142. Hydatid of Morgagni‏‎ (2 revisions)
  143. Gastric heterotopia‏‎ (2 revisions)
  144. Fat embolism‏‎ (2 revisions)
  145. Columnar epithelial dysplasia‏‎ (2 revisions)
  146. Intramucosal carcinoma‏‎ (2 revisions)
  147. Respiratory bronchiolitis-interstitial lung disease‏‎ (2 revisions)
  148. Formula‏‎ (2 revisions)
  149. Endometrium with psammoma bodies‏‎ (2 revisions)
  150. Endoscopic mucosal resection‏‎ (2 revisions)
  151. Inverted papilloma‏‎ (2 revisions)
  152. Lobular breast carcinoma‏‎ (2 revisions)
  153. Invasive ductal carinoma‏‎ (2 revisions)
  154. Pathergy‏‎ (2 revisions)
  155. STUMP‏‎ (2 revisions)
  156. Antiphospholipid antibody syndrome‏‎ (2 revisions)
  157. PowerChart‏‎ (2 revisions)
  158. Section sign‏‎ (2 revisions)
  159. Signs‏‎ (2 revisions)
  160. Fetus papyraceus‏‎ (2 revisions)
  161. Large bowel‏‎ (2 revisions)
  162. Microglandular adenosis‏‎ (2 revisions)
  163. Missed colorectal biopsy‏‎ (2 revisions)
  164. Serrated adenoma‏‎ (2 revisions)
  165. Medullary carcinoma‏‎ (2 revisions)
  166. Malignant rhabdoid tumour‏‎ (2 revisions)
  167. Case 90‏‎ (2 revisions)
  168. Minor salivary gland biopsy‏‎ (2 revisions)
  169. Case 110‏‎ (2 revisions)
  170. World wide web‏‎ (2 revisions)
  171. Next generation sequencing‏‎ (2 revisions)
  172. Lymphangitic carcinomatosis‏‎ (2 revisions)
  173. Bronchiectasis‏‎ (2 revisions)
  174. Flat epithelial atypia‏‎ (2 revisions)
  175. VANTAGE‏‎ (2 revisions)
  176. Eye papilloma‏‎ (2 revisions)
  177. MST‏‎ (2 revisions)
  178. Nodular lymphoid hyperplasia‏‎ (2 revisions)
  179. Leiomyoma of the urinary bladder‏‎ (2 revisions)
  180. An introduction to cardiovascular pathology‏‎ (2 revisions)
  181. Molecular Pathology Rotation Notes‏‎ (2 revisions)
  182. Pillow sign‏‎ (2 revisions)
  183. Villoglandular adenocarcinoma‏‎ (2 revisions)
  184. Eosinophilic enterocolitis‏‎ (2 revisions)
  185. Toxicant-associated steatohepatitis‏‎ (2 revisions)
  186. ATRX‏‎ (2 revisions)
  187. Invasive papillary carcinoma of the breast‏‎ (2 revisions)
  188. Case 79‏‎ (2 revisions)
  189. Case 78‏‎ (2 revisions)
  190. Insular thyroid carcinoma‏‎ (2 revisions)
  191. EM‏‎ (2 revisions)
  192. Mucinous adenocarcinoma of the ovary‏‎ (2 revisions)
  193. Hypoxic-ischemic encephalopathy‏‎ (2 revisions)
  194. Quiz:L4E gastrointestinal pathology (2018)‏‎ (2 revisions)
  195. Steroidogenic factor 1‏‎ (2 revisions)
  196. PAC‏‎ (2 revisions)
  197. Supraclavicular artery island flap‏‎ (2 revisions)
  198. STAT6‏‎ (2 revisions)
  199. Rheumatic heart disease‏‎ (2 revisions)
  200. Rhabdoid tumour‏‎ (2 revisions)
  201. Labial salivary gland‏‎ (2 revisions)
  202. Plume of froth‏‎ (2 revisions)
  203. Anaplastic ologodendroglioma‏‎ (2 revisions)
  204. HELLP syndrome‏‎ (2 revisions)
  205. Lead toxicity‏‎ (2 revisions)
  206. MAC‏‎ (2 revisions)
  207. Madelung's disease‏‎ (2 revisions)
  208. Fistula for hemodialysis‏‎ (2 revisions)
  209. Hematopoietic stem cell transplantation‏‎ (2 revisions)
  210. Clinical medicine‏‎ (2 revisions)
  211. Online Computer Library Center‏‎ (2 revisions)
  212. Tularemia‏‎ (2 revisions)
  213. Shoulder dislocation‏‎ (2 revisions)
  214. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy‏‎ (2 revisions)
  215. Leukoedema‏‎ (2 revisions)
  216. Radical hysterectomy for cervical cancer grossing‏‎ (2 revisions)
  217. Hard palate‏‎ (2 revisions)
  218. Diabetes‏‎ (2 revisions)
  219. SOX11‏‎ (2 revisions)
  220. NordiQC‏‎ (2 revisions)
  221. Epstein-Barr Virus-associated gastric carcinoma‏‎ (2 revisions)
  222. Transanal minimally invasive surgery‏‎ (2 revisions)
  223. Health Sciences Centre‏‎ (2 revisions)
  224. Case 91‏‎ (2 revisions)
  225. Paired box gene 5‏‎ (2 revisions)
  226. Pacinian corpuscles‏‎ (2 revisions)
  227. Myocardial injury after non-cardiac surgery‏‎ (2 revisions)
  228. Esophageal dysplasia‏‎ (2 revisions)
  229. Case 114‏‎ (2 revisions)
  230. Sectioning and extensively examining of the fimbriated end‏‎ (2 revisions)
  231. Immunofluorescence‏‎ (2 revisions)
  232. Cutaneous lymphoma‏‎ (2 revisions)
  233. Skin ellipse‏‎ (2 revisions)
  234. Cholecystitis‏‎ (2 revisions)
  235. Apparent diffusion coefficient‏‎ (2 revisions)
  236. Quiz:L4E rules 1-3 (2018)‏‎ (2 revisions)
  237. Cryptogenic cirrhosis‏‎ (2 revisions)
  238. Not otherwise specified‏‎ (2 revisions)
  239. Dagger‏‎ (2 revisions)
  240. Atypical adenomatous hyperplasia‏‎ (2 revisions)
  241. Collagen vascular diseases‏‎ (2 revisions)
  242. Cirrhosis‏‎ (2 revisions)
  243. Carcinoid tumour‏‎ (2 revisions)
  244. Bowel-associated dermatosis-arthritis syndrome‏‎ (2 revisions)
  245. Carney triad‏‎ (2 revisions)
  246. AKA‏‎ (2 revisions)
  247. CCS‏‎ (2 revisions)
  248. Neoadjuvant therapy‏‎ (2 revisions)
  249. Germ layers‏‎ (2 revisions)
  250. Mucinous cystadenoma‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)